UTHR and MNKD Related Headlines
Go Back- MannKind develops dry powder inhaler for pulmonary hypertension treatment
- MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
- MannKind expands United Therapeutics partnership for second inhaled therapy
- MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
UTHR and MNKD Related Press Releases
Go Back- MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
- MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
